Fulphila (pegfilgrastim)

pCPA File Number: 21097
Negotiation Status:
Concluded with an LOI
Indication(s):
Febrile neutropenia in non-myeloid malignancies
Sponsor/Manufacturer:
BGP Pharma ULC
CDA-AMC Project Number:
SE0588-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: